Printer Friendly

UPJOHN RESPONDS TO DALLAS VERDICT

 UPJOHN RESPONDS TO DALLAS VERDICT
 KALAMAZOO, Mich., Nov. 13 /PRNewswire/ -- Reacting to a Dallas court


verdict yesterday, Theodore Cooper, M.D., Ph.D., Chairman and Chief Executive Officer of The Upjohn Company (NYSE: UPJ), said, "This is a confusing verdict and one which we will certainly appeal."
 The court has not yet entered judgment on the verdict. The amount, if any, that Upjohn will have to pay is uncertain.
 "Upjohn vehemently disagrees with the jury's decision and is pursuing all available means of recourse, including the immediate filing of a motion for judgment notwithstanding the verdict and, if necessary, a motion for a new trial. If these are denied, the company will appeal.
 "We believe that the jury was asked to decide on some highly technical issues, and we stand behind the conclusion of the recent U.S. FDA Psychopharmacological Drug Products Advisory Committee. This group of independent experts reviewed the scientific evidence in May and concluded that Halcion is safe and effective when used as recommended in the labeling," Cooper said.
 A state court jury in Dallas, Texas, yesterday, found The Upjohn Company liable to members of the William Freeman family for damages resulting from Freeman's killing of an acquaintance. Freeman was awarded no compensatory damages. The jury recommended that his wife and children receive a total of $1.6 million in compensatory damages. They also recommended $200,000 in punitive damages based on a finding that Upjohn was grossly negligent. However, the jury found that Upjohn did not exhibit a conscious disregard for human safety and that Upjohn did not act with malice.
 Prior to the jury returning its verdict, the trial court judge decided that Freeman did not prove either of his assertions that Upjohn had committed fraud in regard to submissions to the U.S. Food and Drug Administration (FDA) or that there is a design flaw in Halcion.
 "The jury assigned most of the fault to Freeman and his physician, with only 20 percent allocated to Upjohn. The jurors appear to have concluded that Freeman should be held responsible for his own crime and therefore awarded him no damages. However, they also seemed to sympathize with his family and tried to find a way to give them damages. To do this, they assigned the majority of fault to Mr. Freeman and his physician, but still awarded damages against Upjohn," said Cooper.
 The Upjohn Company is a worldwide, research-based provider of human health care products, animal health products, agronomic and vegetable seeds and specialty chemicals. Headquartered in Kalamazoo, the company has been dedicated to improving health and nutrition for more than a century.
 -0- 11/13/92
 /CONTACT: Kaye P. Bennett of The Upjohn Company, 616-323-4224/
 (UPJ) CO: The Upjohn Company ST: Michigan, Texas IN: MTC SU:


SB -- DE008 -- 0574 11/13/92 09:48 EST
COPYRIGHT 1992 PR Newswire Association LLC
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 1992 Gale, Cengage Learning. All rights reserved.

Article Details
Printer friendly Cite/link Email Feedback
Publication:PR Newswire
Date:Nov 13, 1992
Words:470
Previous Article:ICN PHARMACEUTICALS REPORTS THIRD QUARTER RESULTS /repeating from earlier today/
Next Article:MAZDA MOTOR CORPORATION REPORTS NON-CONSOLIDATED SALES AND EARNINGS FOR FIRST HALF OF FISCAL 1993
Topics:


Related Articles
UPJOHN FILES SUITS TO DEFEND REPUTATION
UPJOHN FILES SUITS TO DEFEND REPUTATION
UPJOHN WINS PATENT INFRINGEMENT SUIT
UPJOHN WINS HALCION CASE
UPJOHN WINS HOUSTON HALCION CASE
UPJOHN WINS LIBEL TRIAL IN U.K.
UPJOHN WINS APPEAL IN TEXAS HALCION CASE
UPJOHN WINS MISSOURI HALCION CASE
UPJOHN WINS APPEALS COURT VERDICT IN DEPO-MEDROL CASE

Terms of use | Copyright © 2016 Farlex, Inc. | Feedback | For webmasters